Get the Stockscreener App
4.93
12.74%
-0.72
Nephros Inc stock is traded at $4.93, with a volume of 297.67K.
It is down -12.74% in the last 24 hours and up +7.17% over the past month.
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.
See More
Previous Close:
$5.65
Open:
$5.65
24h Volume:
297.67K
Relative Volume:
3.92
Market Cap:
$52.39M
Revenue:
$16.68M
Net Income/Loss:
$1.33M
P/E Ratio:
39.44
EPS:
0.125
Net Cash Flow:
$2.00M
1W Performance:
-5.74%
1M Performance:
+7.17%
6M Performance:
+46.73%
1Y Performance:
+206.04%
1-Day Range:
$4.45
$5.76
1-Week Range:
$4.45
$5.9723
52-Week Range:
$1.39
$6.42
Nephros Inc Stock (NEPH) Company Profile
Name
Nephros Inc
Sector
Industry
Phone
201.343.5202
Address
380 LACKAWANNA PLACE, SOUTH ORANGE, NJ
Compare NEPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 1.84 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
3.11 | 4.64B | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.2037 | 469.42M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
GOODO
Gladstone Commercial Corporation
|
20.25 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
4.69 | 201.10M | 0 | 0 | 0 | 0.00 |
|
DAVEW
Dave Inc
|
0.7951 | 0 | 0 | 0 | 0 | 0.00 |
Nephros Inc Stock (NEPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-26-21 | Initiated | B. Riley Securities | Buy |
Nephros Inc Stock (NEPH) Latest News
Nephros Inc NPJP Stock Analysis and ForecastPrice Volatility Patterns & Outstanding Return Stocks - earlytimes.in
What valuation multiples suggest for Nephros Inc. stockStop Loss & Daily Profit Maximizing Tips - Newser
Price to cash flow ratio of Nephros, Inc. – LS:A2PNQ9 - TradingView
Can Nephros Inc. (NPJP) stock surprise with quarterly resultsQuarterly Earnings Report & Expert Approved Momentum Trade Ideas - Newser
How Nephros Inc. stock valuations compare to rivals2025 Volume Leaders & Community Verified Watchlist Alerts - Newser
Operating margin % of Nephros, Inc. – LS:A2PNQ9 - TradingView
Will Nephros Inc. (NPJP) stock profit from AI boom2025 Risk Factors & Consistent Profit Trading Strategies - Newser
Is Nephros Inc. (NPJP) stock undervalued by metrics2025 Institutional Moves & Long Hold Capital Preservation Plans - Newser
Is Nephros Inc. (NPJP) stock prepared for digital transitionEarnings Overview Summary & Expert Approved Momentum Ideas - Newser
Is Nephros Inc. (NPJP) stock a top hedge fund pickWeekly Stock Recap & Growth Focused Entry Point Reports - Newser
How forex fluctuations impact Nephros Inc. (NPJP) stock2025 Trading Volume Trends & Stock Timing and Entry Methods - Newser
Income Plays: Will Nephros Inc stock sustain high P E ratiosMarket Risk Summary & Fast Entry and Exit Trade Plans - BỘ NỘI VỤ
Nephros (NEPH) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Nephros, Inc. Reports Strong Q3 2025 Earnings - MSN
Can Nephros Inc. (NPJP) stock hold up in economic slowdownJuly 2025 Analyst Calls & Intraday High Probability Alerts - BỘ NỘI VỤ
NEPH (Nephros) Operating Margin % : 6.59% (As of Sep. 2025) - GuruFocus
NEPH (Nephros) Days Sales Outstanding : 45.02 (As of Sep. 2025) - GuruFocus
NEPH (Nephros) EV-to-EBITDA : 28.94 (As of Nov. 29, 2025) - GuruFocus
NEPH (Nephros) ROCE % : 12.80% (As of Sep. 2025) - GuruFocus
NEPH (Nephros) ROC (Joel Greenblatt) % : 29.85% (As of Sep. 2025) - GuruFocus
NEPH (Nephros) Days Inventory : 122.76 (As of Sep. 2025) - GuruFocus
Nephros Enters New License Agreement with Medica - MSN
Will Nephros Inc. (NPJP) stock maintain strong growthPortfolio Value Report & Expert Curated Trade Ideas - BỘ NỘI VỤ
Nephros enters license and supply agreement with Medica S.p.A.SEC filing - marketscreener.com
Nephros Enters License And Supply Agreement With Medica S.P.A.SEC Filing - TradingView
Nephros, Inc. Enters into A License and Supply Agreement with Medica S.P.A - marketscreener.com
Nephros inks exclusive Medica supply pact through 2030 - Stock Titan
A2PNQ9 Stock Price and Chart — LS:A2PNQ9 - TradingView
Analyzing Nephros (NASDAQ:NEPH) and Trinity Biotech (NASDAQ:TRIB) - Defense World
Nephros (NASDAQ:NEPH) Trading Down 2.2% – Should You Sell? - Defense World
3 Intriguing Penny Stocks With Market Caps At Least $50M - Yahoo Finance
Can Nephros Inc. (NPJP) stock attract ESG investments2025 Breakouts & Breakdowns & Intraday High Probability Alerts - newser.com
Can Nephros Inc. (NPJP) stock attract analyst upgradesQuarterly Market Summary & Free High Return Stock Watch Alerts - newser.com
Can Nephros Inc. (NPJP) stock deliver double digit returnsTrade Risk Assessment & Daily Volume Surge Signals - newser.com
Topline Capital Management, LLC Increases Stake in Nephros Inc - GuruFocus
Is Nephros Inc. (NPJP) stock a buy before earnings resultsPortfolio Return Summary & Risk Adjusted Buy and Sell Alerts - newser.com
Will Nephros Inc. (NPJP) stock issue positive guidanceMarket Sentiment Summary & Weekly Momentum Stock Picks - newser.com
Best data tools to analyze Nephros Inc. stockWeekly Investment Report & Weekly Watchlist for Hot Stocks - newser.com
Multi asset correlation models including Nephros Inc.Quarterly Trade Review & High Conviction Buy Zone Alerts - newser.com
Published on: 2025-11-19 05:42:32 - newser.com
Nephros Inc Stock (NEPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.05%
0.30%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):